Castle Wealth Management’s Vaxart VXRT Stock Holding History

Castle Wealth Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-500	Closed	-$1K	–	633
2022 Q3	$1K	Hold	500	–	–	﹤0.01%	645
2022 Q2	$2K	Buy	+500	New	+$1.87K	﹤0.01%	597

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Castle Wealth Management's VXRT Position: Q4 2022 in Review

Castle Wealth Management sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 500 shares — an estimated $1K sold.

Castle Wealth Management first reported a position in VXRT in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

Castle Wealth Management reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
Castle Wealth Management sold 500 Vaxart shares in Q4 2022, an estimated $1K.
Castle Wealth Management first reported a position in Vaxart in Q2 2022 and held it in 2 quarters.
Castle Wealth Management's Vaxart position peaked at $2K in Q2 2022.
132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Castle Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.